North America Protein Labelling Market was worth USD 0.58 billion in 2018 and estimated to be growing at a CAGR of 13.56%, to reach USD 1.1 billion by 2023 Protein labelling is done using labelling reagents and kits to label an antibody or other protein, to make an enzyme conjugate, fluorescent probe, biotinylated binding reagent or iodine-labelled tracer for detecting proteins in tissues, cells, and biochemical assays.
The labelling techniques find applications in various biotechnological and pharmaceutical research and diagnostic processes that include protein micro assay, cell-based assay, mass spectrometry, fluorescence microscopy and immunological techniques. The major players in the market have the product portfolio which includes various reagents, kits & services for in-vitro and in-vivo labelling of the specific peptides. Development of advanced dyes that rapidly conjugates with the specific peptides in order to detect their presence and further the purification process more accurately are expected to have a positive impact on growth.
The North America market is witnessing a number of new product launches and improvement in existing technologies that are predicted to accelerate growth in demand. Growing adoption of bioengineering technologies, increasing health care awareness and growing investments in R&D. Moreover, growing proteomics research is boosting the market growth. However, a limited number of skilled professionals, high costs of products are hindering the market growth.
The North America Protein Labelling market is categorised by Product, Labelling method, Application and End users. On the basis of Product, the market is segmented into Reagents, Kits and Services. The Labelling segment includes In vitro Labelling and In vivo Labelling. On the basis of Application, the market is further segmented into Cell-Based Assay, Mass Spectroscopy, Fluorescence Microscopy, Immunological Technique and Protein Microarray. The North America market has been geographically segmented into segmented into US and Canada. North America is the most lucrative region accounting for over 38% of the global revenue in 2016. The market is increasing at a CAGR of 13.56%. Presence of most major players in the region working on enhancing their portfolios on offer and rise in adoption of protein labelling in tandem with the development of genomic sequencing and personalized medicine are the major factors accounting for the region’s dominant position.
The Key companies dominating the North America protein labelling market are Thermo Fisher Scientific, Inc., General Electric Company, Merck KGaA, Eurogentec S.A., PerkinElmer, Inc., F. Hoffmann-La Roche AG, New England Biolabs, Kaneka Corporation, Kirkegaard & Perry Laboratories, Promega Corporation, LI-COR, Inc. and SeraCare Life Sciences, Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Product
5.1.1 Introduction
5.1.2 Reagents
5.1.2.1 Enzymes
5.1.2.2 Monoclonal Antibodies
5.1.2.3 Proteins
5.1.2.4 Probes/Tags
5.1.2.5 Other Reagents
5.1.3 Kits
5.1.4 Services
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Labeling Method
5.2.1 Introduction
5.2.2 In vitro Labeling
5.2.2.1 Enzymatic Labeling
5.2.2.2 Dye-Based Labeling
5.2.2.3 Cotranslational Labeling
5.2.2.4 Site-Specific Labeling
5.2.2.5 Nanoparticle Labeling
5.2.3 In vivo Labeling
5.2.3.1 Photoreactive Labeling
5.2.3.2 Radioactive Labeling
5.2.4 Bioorthogonal Labeling
5.2.5 Y-o-Y Growth Analysis, By Type
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By Type
5.3 Application
5.3.1 Introduction
5.3.2 Cell-Based Assay
5.3.3 Mass Spectroscopy
5.3.4 Fluorescence Microscopy
5.3.5 Immunological Technique
5.3.6 Protein Microarray
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
5.4 End user
5.4.1 Introduction
5.4.2 Y-o-Y Growth Analysis, By End user
5.4.2 Market Attractiveness Analysis, By End user
5.4.3 Market Share Analysis, By End user
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Labeling Method
6.1.3.4 By Application
6.1.3.5 By End user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Labeling Method
6.1.4.4 By Application
6.1.4.5 By End user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Labeling Method
6.1.5.4 By Application
6.1.5.5 By End user
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Thermo Fisher Scientific, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 General Electric Company
8.3 Merck KGaA
8.4 Eurogentec S.A.
8.5 PerkinElmer, Inc.
8.6 F. Hoffmann-La Roche AG
8.7 New England Biolabs
8.8 Kaneka Corporation
8.9 Kirkegaard & Perry Laboratories
8.10 Promega Corporation
8.11 LI-COR, Inc.
8.12 SeraCare Life Sciences, Inc.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
Appendix
